sulfasalazine has been researched along with Gangrene in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Gangrene: Death and putrefaction of tissue usually due to a loss of blood supply.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alamlih, L | 1 |
| Al-Karaja, L | 1 |
| Amro, D | 1 |
| Alnatsheh, M | 1 |
| Asghar, SS | 1 |
| Bos, JD | 1 |
| Kammeijer, A | 1 |
| Cormane, RH | 1 |
2 other studies available for sulfasalazine and Gangrene
| Article | Year |
|---|---|
Sulfasalazine induced leukocytoclastic vasculitis resulting in gangrene.
Topics: Gangrene; Humans; Sulfasalazine; Vasculitis, Leukocytoclastic, Cutaneous | 2023 |
Immunologic and biochemical studies on a patient with pyoderma gangrenosum.
Topics: Drug Combinations; Gangrene; Glucosamine; Humans; Immunoglobulins; Male; Middle Aged; Pyoderma; Sulf | 1984 |